Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC14080Apogossypolone (ApoG2)CAS: 886578-07-0
Apogossypolone (ApoG2) (ApoG2) 是一种具有口服活性的 Bcl-2 家族蛋白抑制剂,对 Bcl-2、Mcl-1 和 Bcl-XL 的 Ki 值分别为 35、25 和 660 nM。
- GC16866Actinomycin DCAS: 50-76-0纯度: >98.00%
阿克替诺霉素D(也称为达克替诺霉素)是一种从链霉菌属中分离出来的天然色胺肽,含有一个杂环色团和两个五元环戊肽内酯环。
- GC12658PhiKan 083CAS: 880813-36-5纯度: >98.00%
PhiKan 083 是一种咔唑衍生物,可与表面腔结合并稳定 Y220C(一种 p53 突变体),Kd 为 167 μM。 PhiKan 083 可用于癌症研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC13687 | NSC 66811 | 6964-62-1 | >98.00% | |
A potent inhibitor of Mdm2-p53 interaction | ||||
| GC14080 | Apogossypolone (ApoG2) | 886578-07-0 | - | |
Apogossypolone (ApoG2) (ApoG2) 是一种具有口服活性的 Bcl-2 家族蛋白抑制剂,对 Bcl-2、Mcl-1 和 Bcl-XL 的 Ki 值分别为 35、25 和 660 nM。 | ||||
| GC15035 | PM00104 | 308359-57-1 | - | |
Potent antimyeloma agent | ||||
| GC15036 | Raltegravir potassium salt | 871038-72-1 | >98.00% | |
An HIV-1 integrase inhibitor | ||||
| GC15066 | Z-FA-FMK | 197855-65-5 | >98.00% | |
An inhibitor of cysteine proteases, including cathepsin B | ||||
| GC15480 | Marinopyrrole A | 1227962-62-0 | >99.50% | |
An alkaloid with antibacterial activity | ||||
| GC15840 | CP 31398 dihydrochloride | 1217195-61-3 | >99.00% | |
A p53 stabilizing agent | ||||
| GC16590 | Dimethyl Fumarate | 624-49-7 | >97.00% | |
An antioxidant with immunological actions | ||||
| GC16866 | Actinomycin D | 50-76-0 | >98.00% | |
阿克替诺霉素D(也称为达克替诺霉素)是一种从链霉菌属中分离出来的天然色胺肽,含有一个杂环色团和两个五元环戊肽内酯环。 | ||||
| GC10650 | HLI 373 | 502137-98-6 | - | |
HLI 373 是一种有效的 Hdm2 抑制剂。 | ||||
| GC13171 | AZ 10417808 | 331645-84-2 | - | |
Caspase-3 inhibitor,selective non-peptide | ||||
| GC15404 | NSC 319726 | 71555-25-4 | >98.00% | |
A p53 reactivator | ||||
| GC15828 | AMG232 | 1352066-68-2 | >98.00% | |
An inhibitor of the MDM2 and p53 interaction | ||||
| GC12893 | MIRA-1 | 72835-26-8 | >98.00% | |
MIRA-1是一种马来酰亚胺类化合物,能够恢复突变型p53的野生型构象及功能。 | ||||
| GC15878 | Atractyloside Dipotassium Salt | 102130-43-8 | >99.50% | |
Inhibitor of ADP/ATP translocases | ||||
| GC17969 | CHM 1 | 154554-41-3 | - | |
An inhibitor of tubulin polymerization | ||||
| GC18137 | Ivachtin | 745046-84-8 | >98.00% | |
A reversible caspase-3 inhibitor | ||||
| GC14886 | PETCM | 10129-56-3 | - | |
PETCM 是 caspase-3 的激活剂,并以细胞色素 c (细胞 c) 依赖性方式发挥作用。 PETCM 促进 Apaf-1 寡聚化并诱导 HeLa 细胞中的细胞凋亡。 | ||||
| GC15621 | NSC 146109 hydrochloride | 59474-01-0 | >98.00% | |
An activator of p53 | ||||
| GC12658 | PhiKan 083 | 880813-36-5 | >98.00% | |
PhiKan 083 是一种咔唑衍生物,可与表面腔结合并稳定 Y220C(一种 p53 突变体),Kd 为 167 μM。 PhiKan 083 可用于癌症研究。 | ||||
| GC15484 | Deguelin | 522-17-8 | >99.00% | |
Deguelin是四种主要天然鱼藤酮类化合物之一,从植物根部提取物中分离得到,最为人熟知的是其作为NADH:泛醌氧化还原酶(复合体I)抑制剂的作用,可导致线粒体功能的显著改变。 | ||||
| GC15987 | BIM, Biotinylated | - | - | |
Bim peptide fragment with a biotin moiety attached | ||||
| GC10589 | RETRA hydrochloride | 1036069-26-7 | - | |
Antitumor agent | ||||
| GC12046 | iMAC2 | 335166-00-2 | >98.00% | |
iMAC2 是一种有效的 MAC 抑制剂,IC50 为 28 nM,LD50 为 15000 nM。 | ||||
